93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details

臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00844402 (ClinicalTrials.gov)	January 2006	13/2/2009	Safety and Efficacy of Long-Term Treatment With Atorvastatinin Patients With Primary Biliary Cirrhos ...	Safety and Efficacy of Long-Term Treatment With Atorvastatinin Patients With Primary Biliary Cirrhos ...	Primary Biliary Cirrhosis;Hypercholesterolemia	Drug: Atorvastatin	Medical University of Graz	NULL	Completed	18 Years	70 Years	Both	40	Phase 3	Austria
2	EUCTR2005-002160-28-AT (EUCTR)	23/09/2005	19/08/2005	Safety and efficacy of long-term treatment with atorvastatinin patients with primary biliary cirrhos ...	Safety and efficacy of long-term treatment with atorvastatinin patients with primary biliary cirrhos ...	Reduction of cardiovascular risk may become key for the management of PBC. Therefore information on ...	Trade Name: Sortis Product Name: Sortis 10 mg INN or Proposed INN: Atorvastatin	Medical University Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology ...	NULL	Not Recruiting			Female: yes Male: yes	80		Austria

First Previous1Next Last